Photo from The Netherlands Cancer Institute/X
Jun 7, 2024, 09:11
Results of the NICHE-2 study by Myriam Chalabi – The Netherlands Cancer Institute
The Netherlands Cancer Institute (NKI) shared on X:
“More success for neoadjuvant immunotherapy: results of the NICHE-2 study by Myriam Chalabi show that it is highly effective in a subset of patients with colon cancer.
In 68% of patients there were no live cancer cells.”
Source: The Netherlands Cancer Institute/X
Jul 1, 2024, 19:16